Teva Pharm prices $15 bln in **tes to fund Allergan generics deal
 

Teva Pharm prices $15 bln in **tes to fund Allergan generics deal

TEL AVIV, July 19 (Reuters) – Teva Pharmaceutical Industries
Ltd said on Tuesday it successfully priced a debt
offering for $15 billion worth of senior **tes to help fund its
acquisition of Allergan…http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...ns:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...ns:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/gCuij3eynGY